Published on in Vol 19, No 8 (2017): August

“Am I normal?” The Wishes of Patients With Lymphoma to Compare Their Patient-Reported Outcomes With Those of Their Peers

“Am I normal?” The Wishes of Patients With Lymphoma to Compare Their Patient-Reported Outcomes With Those of Their Peers

“Am I normal?” The Wishes of Patients With Lymphoma to Compare Their Patient-Reported Outcomes With Those of Their Peers

Journals

  1. Weitzman E, Magane K, Wisk L. How Returning Aggregate Research Results Impacts Interest in Research Engagement and Planned Actions Relevant to Health Care Decision Making: Cohort Study. Journal of Medical Internet Research 2018;20(12):e10647 View
  2. Arts L, Oerlemans S, Tick L, Koster A, Roerdink H, van de Poll-Franse L. More frequent use of health care services among distressed compared with nondistressed survivors of lymphoma and chronic lymphocytic leukemia: Results from the population-based PROFILES registry. Cancer 2018;124(14):3016 View
  3. Lehmann J, Wintner L, Sztankay M, Willenbacher W, Weger R, Weyrer W, Rumpold G, Holzner B. Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring. memo - Magazine of European Medical Oncology 2020;13(3):285 View
  4. de Rooij B, Ezendam N, Mols F, Vissers P, Thong M, Vlooswijk C, Oerlemans S, Husson O, Horevoorts N, van de Poll-Franse L. Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry. Quality of Life Research 2018;27(12):3313 View
  5. Thieblemont C, Howlett S, Casasnovas R, Mounier N, Perrot A, Morschhauser F, Fruchart C, Daguindau N, Eygen K, Obéric L, Bouabdallah R, Pica G, Nicolas‐Virezelier E, Abraham J, Fitoussi O, Snauwaert S, Eisenmann J, Lionne‐Huyghe P, Bron D, Tricot S, Deeren D, Gonzalez H, Costello R, Le Du K, Silva M, Grosicki S, Trotman J, Catalano J, Caballero D, Greil R, Cohen A, Gaulard P, Roulin L, Takeshita K, Casadebaig M, Tilly H, Coiffier B. Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study. British Journal of Haematology 2020;189(1):84 View
  6. Mols F, Husson O, Oudejans M, Vlooswijk C, Horevoorts N, van de Poll-Franse L. Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women. Acta Oncologica 2018;57(10):1381 View
  7. Sztankay M, Neppl L, Wintner L, Loth F, Willenbacher W, Weger R, Weyrer W, Steurer M, Rumpold G, Holzner B. Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient‐reported outcome assessment for the Austrian Myelome Registry. European Journal of Cancer Care 2019;28(6) View
  8. Thong M, Mols F, Doege D, van de Poll-Franse L, Arndt V. Population-based cancer survivorship research: Experiences from Germany and the Netherlands. Journal of Cancer Policy 2018;15:87 View
  9. Derksen J, Beijer S, Koopman M, Verkooijen H, van de Poll-Franse L, May A. Monitoring potentially modifiable lifestyle factors in cancer survivors: A narrative review on currently available methodologies and innovations for large-scale surveillance. European Journal of Cancer 2018;103:327 View
  10. Vromans R, Pauws S, Bol N, van de Poll-Franse L, Krahmer E. Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?. BMC Medical Informatics and Decision Making 2020;20(1) View
  11. Leahy A, Schwartz L, Li Y, Reeve B, Bekelman J, Aplenc R, Basch E. Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy. Cancer 2021 View